Compounds > trofosfamide
Page last updated: 2024-08-24

trofosfamide and Skin Neoplasms

trofosfamide has been researched along with Skin Neoplasms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Atzpodien, J; Fluck, M; Morawek, L; Reitz, M1
Coras, B; Hafner, C; Hohenleutner, U; Landthaler, M; Reichle, A; Szeimies, RM; Vogt, T1
Mauch, C1
Enk, AH; Knop, J1

Other Studies

4 other study(ies) available for trofosfamide and Skin Neoplasms

ArticleYear
Bleomycin, vinorelbine and trofosfamide in relapsed stage IV cutaneous malignant melanoma patients.
    Cancer chemotherapy and pharmacology, 2009, Volume: 64, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Female; Humans; Kaplan-Meier Estimate; Karnofsky Performance Status; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Skin Neoplasms; Survival Analysis; Vinblastine; Vinorelbine

2009
Antiangiogenic therapy with pioglitazone, rofecoxib, and trofosfamide in a patient with endemic kaposi sarcoma.
    Archives of dermatology, 2004, Volume: 140, Issue:12

    Topics: Adult; Angiogenesis Inhibitors; Cyclophosphamide; Drug Therapy, Combination; Endemic Diseases; Humans; Lactones; Male; Mozambique; Pioglitazone; Sarcoma, Kaposi; Skin Neoplasms; Sulfones; Thiazolidinediones; Treatment Outcome

2004
[Metronomic chemotherapy. Should we change our thinking in the treatment of advanced tumors?].
    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2005, Volume: 3, Issue:1

    Topics: Administration, Oral; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Bevacizumab; Breast Neoplasms; Busulfan; Cyclooxygenase 2 Inhibitors; Cyclophosphamide; Drug Therapy, Combination; Female; Forecasting; Humans; Male; Melanoma; Neoplasm Metastasis; Neoplasms; Prospective Studies; Quality of Life; Skin Neoplasms; Time Factors; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A

2005
[Stabilizing the course of patients with stage IV advanced malignant melanoma by trofosfamide treatment].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2000, Volume: 51, Issue:7

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Alkylating; Cyclophosphamide; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Melanoma; Middle Aged; Skin Neoplasms; Treatment Outcome

2000